In the years following the description of antibodies against AQP4 (AQP4‐IgG), multiple clinical observations revealed AQP4 seropositivity also in patients with clinical syndromes not fulfilling the strict NMO criteria. This evidence concerns the gene AQP4 and neuromyelitis optica.